Rafferty Asset Management’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Buy |
7,587
+882
| +13% | +$193K | 0.01% | 652 |
|
|
2025
Q1 | $1.5M | Sell |
6,705
-1,513
| -18% | -$339K | 0.01% | 654 |
|
|
2024
Q4 | $2.69M | Buy |
8,218
+860
| +12% | +$282K | 0.01% | 560 |
|
|
2024
Q3 | $2.21M | Sell |
7,358
-572
| -7% | -$172K | 0.01% | 608 |
|
|
2024
Q2 | $2.61M | Buy |
7,930
+292
| +4% | +$96.2K | 0.01% | 570 |
|
|
2024
Q1 | $3.02M | Buy |
7,638
+112
| +1% | +$44.3K | 0.01% | 583 |
|
|
2023
Q4 | $2.65M | Sell |
7,526
-179
| -2% | -$63K | 0.01% | 596 |
|
|
2023
Q3 | $2.89M | Buy |
7,705
+510
| +7% | +$191K | 0.02% | 508 |
|
|
2023
Q2 | $2.75M | Buy |
7,195
+578
| +9% | +$221K | 0.02% | 556 |
|
|
2023
Q1 | $2.29M | Buy |
6,617
+263
| +4% | +$91.1K | 0.02% | 568 |
|
|
2022
Q4 | $1.5M | Buy |
6,354
+2,394
| +60% | +$563K | 0.01% | 656 |
|
|
2022
Q3 | $974K | Buy |
3,960
+2,163
| +120% | +$532K | 0.01% | 689 |
|
|
2022
Q2 | $543K | Sell |
1,797
-467
| -21% | -$141K | 0.01% | 787 |
|
|
2022
Q1 | $930K | Sell |
2,264
-225
| -9% | -$92.4K | 0.01% | 795 |
|
|
2021
Q4 | $1.17M | Buy |
2,489
+130
| +6% | +$61K | 0.01% | 807 |
|
|
2021
Q3 | $1M | Buy |
2,359
+637
| +37% | +$270K | 0.01% | 822 |
|
|
2021
Q2 | $618K | Buy |
1,722
+144
| +9% | +$51.7K | ﹤0.01% | 1028 |
|
|
2021
Q1 | $445K | Buy |
1,578
+115
| +8% | +$32.4K | ﹤0.01% | 987 |
|
|
2020
Q4 | $414K | Sell |
1,463
-86
| -6% | -$24.3K | ﹤0.01% | 729 |
|
|
2020
Q3 | $426K | Sell |
1,549
-5,057
| -77% | -$1.39M | 0.01% | 732 |
|
|
2020
Q2 | $1.5M | Buy |
+6,606
| New | +$1.5M | 0.02% | 431 |
|